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Effectiveness and costs of a vocational advice
service to improve work outcomes in patients with
musculoskeletal pain in primary care: a cluster
randomised trial (SWAP trial ISRCTN 52269669)
Gwenllian Wynne-Jonesa,*, Majid Artusa, Annette Bishopa, Sarah A. Lawtonb, Martyn Lewisa,b, Sue Jowetta,c,
Jesse Kigozia,c, Chris Maina, Gail Sowdena,d, Simon Wathalla,b, A. Kim Burtone, Danielle A. van der Windta,
Elaine M. Haya, Nadine E. Fostera,b, the SWAP Study Team
Abstract
Musculoskeletal pain is acommoncauseofworkabsence, andearly intervention is advocated toprevent theadversehealth andeconomic
consequences of longer-term absence. This cluster randomised controlled trial investigated the effect of introducing a vocational advice
service into primary care to provide occupational support. Six general practices were randomised; patients were eligible if they were
consulting their general practitionerwithmusculoskeletal pain andwere employed and struggling atwork or absent fromwork,6months.
Practices in the intervention arm could refer patients to a vocational advisor embedded within the practice providing a case-managed
stepwise intervention addressing obstacles toworking. The primary outcomewas number of days off work, over 4months. Participants in
the intervention arm (n5 158) had fewer days work absence compared with the control arm (n5 180) (mean 9.3 [SD 21·7] vs 14·4 [SD
27·7]) days, incidence rate ratio 0·51 (95%confidence interval 0·26, 0·99),P50·048). Thenet societal benefit of the intervention compared
with best care was £733: £748 gain (work absence) vs £15 loss (health care costs). The addition of a vocational advice service to best
current primary care for patients consultingwithmusculoskeletal pain led to reduced absence and cost savings for society. If a similar early
intervention to the one tested in this trial was implementedwidely, it could potentially reducedays absent over 12monthsby 16%, equating
to an overall societal cost saving of approximately £500 million (US $6 billion) and requiring an investment of only £10 million.
Keywords: Cluster randomised controlled trial, Vocational advice, Occupational advice, Musculoskeletal pain, Primary care
1. Introduction
Musculoskeletal pain is one of the most common causes of work
absence.2,7 Across Europe, almost a quarter of workers will
experience pain in their neck, shoulders, or upper limbs, and an
estimated half of the European workforce will experience back
pain at some point in their lives at a cost of approximately €12
billion overall.34 The cost of work absence attributed to
musculoskeletal pain in European Union countries is between
0.5% and 2.0% of national gross domestic product34; pain also
has a considerable impact on individuals’ earnings and associ-
ated costs to the state in benefit payments.30 In the United
Kingdom, the estimated costs in 2003 for general practitioner
(GP) consultations only as a result of musculoskeletal conditions
were £1.34 million.12 The prevalence and incidence of many
musculoskeletal conditions increase with older age; this, coupled
with the rising retirement age, means that the impact of
musculoskeletal pain on the workforce will rise further.34
Remaining active at work, despite pain, has been demon-
strated to be beneficial to individuals and employers resulting in
less sickness absence, less time on modified duties, and
a reduction in pain recurrence.30 Intervening early when employ-
ees report musculoskeletal pain can have a significant impact on
their ability to remain in work.5,31 However, the provision of
independent occupational health services is scarce, and for the
majority of working age people, the first port of call for advice is
their GP.5 In the United Kingdom, theGP is also the gatekeeper to
health-related benefits through the “Fit Note” system whereby
absence of greater than 7 days is sanctioned. However, many
GPs report that they feel ill equipped to manage occupational
health issues and have had little or no training in the use of Fit
Notes.16 Previous initiatives to address health and work have
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been aimed primarily at those with longer-term absence.1,23
However, given the evidence that the longer an individual is out of
work, the less likely it is that they will return, intervening before an
individual experiences long-term absence may be beneficial to
both the individual and wider society.
Primary care is likely to be the ideal setting in which to offer
patients early access to appropriate occupational health support,
also termed vocational advice, occupational advice, and work-
place coaching in the literature. Although there are guidelines in
place to support primary care practitioners in providing appro-
priate advice and support about work, implementation of these is
variable.3 Improvement in training and education aboutmanaging
occupational health in primary care should be coupled with
provision of services to which patients may be referred for advice
and assistance about work.
The aim of this cluster randomised controlled trial was to
determine whether the addition of a vocational advice (VA) service
to best current primary care can reduce work absence in patients
consulting their GP for musculoskeletal pain who are either
absent from work or struggling to remain in work because of their
pain.
2. Methods
2.1. Study design and participants
The methods are reported in full in the published protocol.4 The
Study of Work and Pain (SWAP) was a pragmatic, cluster
randomised controlled trial in primary care with 2 parallel arms, an
economic evaluation, and linked qualitative interviews (reported
separately). The unit of randomisation was the general practice
with data collected from individual participants.
Consenting GP practices were randomly assigned to provide
either best current primary care for managing the impact of
musculoskeletal conditions on work or the same best care plus
the addition of a VA service, located in the practice and staffed by
trained VAs who provided occupational advice about working
with musculoskeletal pain. General practitioner practices were
eligible for participation if they were located in the National
Institute of Health Research Clinical Research Network: West
Midlands (NIHR CRN: WM), which supports delivery of research
within primary care practices in the region. Recruitment took
place between 2012 and 2014, and participants were followed up
4 and 12 months later. Patients were eligible for participation if
they were consulting with musculoskeletal pain, aged 18 to 70
years, currently in paid employment, had current sickness
absence due to musculoskeletal pain of less than 6 months
duration (either GP or self-certified and either first consultation for
a Fit Note or a repeat consultation for a Fit Note), or were
considered by the GP or nurse practitioner (NP) to be struggling
with work because of musculoskeletal pain. Patients were not
eligible for participation if they met any of the following criteria (full
criteria are reported in the protocol)4: Patients with symptoms
indicative of possible serious pathology, requiring urgent medical
attention; those who have long-term work absence (greater than
6 months); and those with serious mental health problems.
Eligible patients were identified when they consulted their GP/NP
and were introduced to the study and given an information pack.
The pack contained a letter of invitation, participant information
sheet, consent form to participate in the research evaluation of
the service, self-completion questionnaire, and a prepaid reply
envelope. Eligible patients, not identified during the consultation,
were later identified by the NIHR CRN: WM through regular
medical record reviews (see published protocol for full details).4
Selection bias was minimised in this cluster trial through identical
methods of participant identification, invitation, and recruitment at
both intervention and control practices.
A trial steering committee and independent Data Monitoring
Committee oversaw the trial. The National Research Ethics
Service West Midlands—Staffordshire in the United Kingdom
approved the protocol (REC reference: 12/WM/0020), and the
trial was registered at ISRCTN 52269669.
2.2. Randomisation and masking
General practitioner practices were the unit of randomisation.
Practices were matched on registered population list size; the
matched practices were randomly allocated to the intervention or
control arms by stratified block randomisation. The random-
isation process within the individual blocks was computer
generated by the trial statistician. General practitioners, NPs,
and VAs could not bemasked to allocation. Individual participants
were informed that local musculoskeletal services were being
evaluated and their consent was sought to participate in data
collection and medical record review. The data were analysed
independently by 2 statisticians, one of whom was masked to
intervention allocation.
2.3. Interventions
Both intervention and control practices provided best current
work-focussed primary care. The provision of best current care
was supported by providing GPs and NPs with an education
session lasting 1 hour. This emphasised 4 keymessages: (1) work
is usually good for people with musculoskeletal pain, (2) long
periods of absence are generally harmful, (3) musculoskeletal
pain can generally be accommodated at work, and (4) planning
and supporting return to work are important aspects of clinical
management.20,30
The intervention practices also hosted a new VA service,4 and
GPs and NPs could refer patients to the service whether, or not,
patients consented to take part in the research evaluation.
Patients referred to the VA were contacted 5 working days after
referral. Initial contact was by telephone (step 1), with 1 or more
face-to-face meetings (step 2) and contact with employers (step
3) being held subsequently, if required. Vocational advisors used
the “psychosocial flags framework”20 to assist patients in
identifying and overcoming obstacles to returning to or remaining
in work with their musculoskeletal pain. The VAs focussed
discussions on 3 main areas: (1) psychological or behavioural
obstacles to working, eg, beliefs about pain, illness behaviours
(yellow flags)19; (2) work perceptions, eg, the beliefs about the
physical and social impact of work on health (blue flags)28; and (3)
context factors, eg, objective working conditions and character-
istics, and financial impact of working status such as job security
and benefit entitlements (black flags).20 The VA and patient jointly
developed a plan to manage health and work issues and to
support the patient in addressing identified obstacles, with
regular review. The VA also ensured that the patient’s GP was
included in communications using the practice communications
system linked to the patient’s medical record. This ensured that
clinical issues identified as obstacles to work could be
communicated to the GP for resolution and that return-to-work
plans could also be provided to the GP. Four health care
practitioners were recruited to the VA role to deliver the service; 3
physiotherapists and 1 nurse (all VA was actually delivered by the
3 physiotherapists), all completed a 4-day training course
(developed by the study team and reported separately) and half
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day update before the start of the service. The VAs were new
recruits to this role and did not provide any other services to the
general practice. The service was “low intensity” and based on
the principles of case management using a stepped care
model to develop a goal-orientated approach to remaining in
or returning to work (Fig. 1), along with the intention of getting
the key players (person, health care, and workplace) onside.20
Patients continued to be eligible for VA until they achieved
a sustained return to work (the patient returns to work and
does not initiate contact with the VA for a period of at least 2
weeks) and felt able to manage their musculoskeletal pain in
the context of their work, or until they had been absent from the
workplace for a total of 6 months and qualified for Employment
and Support Allowance.
2.4. Outcomes
Demographic data, health, andwork datawere collected after GP
consultation and, in the intervention practices, before an
appointment with the VA, and at 4- and 12-month follow-up.
Full details of the primary and secondary outcomes collected are
provided in the protocol.4
The primary outcome measure was number of days off work
over 4 months, measured at the individual participant level.
Work absence was identified at follow-up based on the
following self-reported questions: “Have you taken time off
work during the last 4 months (since your last questionnaire)
because of your pain?,” “If yes, please write the number of
days, weeks or months you were off work due to your pain in
the last 4 months.” “Days off work” in this context captures
periods of self-certified absence as well as GP-certified
absence. For the purposes of this trial, 1 week was classified
as 5 days and 1 month as 21 days. Further analysis of time off
work examined any self-reported time off work (binary yes/no)
and GP-certified periods over 12months of follow-up identified
from the medical record. Secondary outcome measures
included pain intensity (0-10 numerical rating scale), bother-
someness (1-5 rating scale),10 global assessment of change
(5-point rating of general health from excellent to poor), self-
efficacy to return to work (Self-efficacy to Return-to-Work
Questionnaire),29 work presenteeism (Stanford Presenteeism
Scale 6),21 and self-rated work performance (0-10 numerical
rating scale).
2.5. Statistical analysis
For the primary outcome (days off work over 4 months), the
analysis was by hierarchical negative binomial regression adjust-
ing for age, sex, and GP practice size (at the GP cluster level).13
The best-fitting model according to goodness-of-fit (higher log
likelihood, and lower Akaike information criterion and Bayesian
information criteria) was given by a zero-inflated model; hence,
the hierarchical zero-inflated negative binomial regression was
used for the analysis of time off work over 4 months (primary) and
12 months (secondary). Given the limited number of GP
practices, the hierarchical model included individual practitioners
(GPs and NPs) at the cluster level; differences in GP behaviours
are known to be a major influence in varying sickness certification
prescribing practice.32 Longitudinal mixed models (linear or
generalised as appropriate to numerical and categorical outcome
data, respectively) were fitted to estimate and test for between-
group effects across other outcome measures, adjusting for
baseline covariates (age, sex, and GP practice size). An intention-
to-treat analysis was followed. The statistical analysis followed
the plans described in the published protocol,4 and the final
version of the statistical analysis plan agreed with the Data
Monitoring Committee.
2.6. Sensitivity analyses
(1) Evaluation of the primary outcome measure (number of days
off work by robust Poisson and zero-inflated models)
(2) Evaluation of the primary outcome measure (number of days
off work) by a zero-inflated negative binomial model with robust
variance estimator17 adjusted for (1) age, sex, and practice size
and (2) adjusted for age, sex, practice size plus baseline pain
scores, and days off work over the past 12 months.
(3) Evaluation of the primary outcome measure using the GP
practice as the unit of clustering rather than the individual GP/
NP practitioner, including GP practice as a random factor
intercept in the hierarchical model.
(4) A per protocol evaluation (and complier average causal effect
evaluation) comparing time off work for those participants in the
intervention practices who engaged with any aspect of the VA
service (at least 1 contact with a VA) vs (1) all control arm
participants, (2) “comparable” participants in the control
practices that would be expected to similarly adhere with
treatment protocol—via an instrumental variable analysis
Figure 1. Model of stepped care provided by the vocational advisor (VA). RTW, return to work.
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(adherence/nonadherence, defined as at least 1 contact with
the VA).
2.7. Subgroup analyses
Exploratory evaluation of the primary outcome was performed to
examine whether time off work appeared differed between
subgroups. The 3 subgroup analyses agreed and documented
in the statistical analysis plan were baseline return-to-work self-
efficacy, location of pain (spinal pain vs pain in other areas), and
duration of work absence (at least 10 days vs/less than 10 days).
Statistical estimates were obtained through including interaction
terms in the statistical model of treatment effect.
2.8. Sample size
The sample size calculation was based on the ability to detect
a between-group difference of at least 10 days off work at 4
months, given an expected SD of 25 days,33 80% power, and 5%
2-tailed significance level. The sample size takes into account (1)
30% inflation through clustering of data (at practitioner level)
based on an intracluster correlation coefficient for between-
practitioner effects of 0.05,22 variation in expected VA service
referral rates between GPs (based on an expected coefficient of
variation of 0.65),11 and (2) 25% inflation through allowance for
20% loss to follow-up at 4 months. This resulted in a required
sample size of 330 participants (165 per arm).
2.9. Economic evaluation
An incremental cost-effectiveness analysis was undertaken
using mean days off work as the measure of outcome, to
calculate the cost per sick day avoided, from a health care
perspective. Patient-level health care costs concentrated on
National Health Service (NHS) and private health care resource
use for musculoskeletal pain obtained from patient question-
naires at 4 and 12 months, and additional costs of the VA
service (eTable 1, available online at http://links.lww.com/
PAIN/A489). Hierarchical modelling was used to estimate
differential costs and differential quality-adjusted life years
controlling for the treatment arm and clustering.15 Details of
contact with the VAs were obtained through case report forms.
Unit cost data relating to resource use are reported in eTable 2
(available online at http://links.lww.com/PAIN/A489), and
a price year of 2013 was used, with costs presented in UK
pounds (£). A cost–benefit approach was used to generate
a net societal benefit and return on investment (ROI) of using
the VA service. Wider societal costs in relation to the VA
intervention were assigned to self-reported work absence
using the human capital approach by multiplying days off work
during follow-up by the Standard Occupational Classification–
related (2010 edition) respondent-specific wage rates.
Discounting was not performed because of the 12-month
follow-up period.
2.10. Public and patient involvement and engagement
Patients with musculoskeletal pain and primary care clinicians
involved in their treatment were involved throughout the SWAP
trial and were independent from those participating in the trial.
Public and patient involvement and engagement representatives
were involved in the development of the research question and
were active members of the grant application with additional
members involved in the trial steering committee and providing
advice on all aspects of the design, recruitment, and retention
methods, as well as reviewing all patient-facing materials.
3. Results
3.1. Recruitment
Twenty general practices were approached with 6 general
practices being eligible; they were randomised, 3 to the
intervention and 3 to the control arms. Participants were recruited
between July 2012 and January 2014; Figure 2 shows the flow of
participants through the trial. A total of 338 participants
consented to participate in the research data collection after
their consultation at participating practices, 158 to the
intervention and 180 to the control arms. Follow-up was 75%
(n5 119) and 69% (n5 109) at 4 and 12 months, respectively, in
the intervention arm and 82% (n 5 148) and 73% (n 5 131) at 4
and 12 months, respectively, in the control arm.
3.2. Baseline characteristics
Table 1 reports the baseline characteristics of participants, which
were comparable. The mean age was 49.5 and 47.9 years, with
56% and 59% women in the intervention and control arms,
respectively. Most participants were working full time. Partic-
ipants in the control arm reported that they had marginally more
days of work absence in the previous 12 months. At baseline,
duration of symptoms, measures of pain intensity, and bother-
someness were similar in both arms.
3.3. Adherence with treatment protocol
Of the 158 participants in the intervention practices, 120 (76%)
were referred to the VA service (Fig. 2). Of these, 97 (81%) had at
least 1 contact with a VA. The average number of contacts
between the VAs and patients was 2, with the majority of these
being telephone contacts (89%) lasting an average of 13.3
minutes (Table 2). Exploration of health and work issues were
frequently recorded by the VAs on case report forms, but return-
to-work planning was not commonly recorded.
3.4. Primary outcome
3.4.1. Four months
At 4 months, there was some evidence for effect in the number of
days off work between arms with the intervention arm reporting
fewer days off work mean of 9.3 (SD 21.7) days compared with
14.4 (SD 27.7) days in the control arm, an adjusted incidence rate
ratio (IRR) of 0.51 (P 5 0.048). Results of the sensitivity analyses
including different model estimation, nonparametric testing, per
protocol/complier average causal effect complier evaluation, and
accounting for clustering at GP practice level concurred with the
primary analysis in showing greater time (days) off work in the
control arm (Table 3). The difference in days off work was largely
accounted for by the lower number of GP-certified days in the
intervention arm at 8.4 (SD 21.0) days vs 13.5 (27.5) days in the
control arm (P 5 0.020) (Table 3).
3.4.2. Twelve months
By 12 months, there was no overall statistically significant
difference in the cumulated number of days of work absence
between arms. However, the intervention arm reported fewer
days off work certified by the GP at amean of 16.4 (SD 34.2) days
comparedwith 22.9 (SD 50.5) days in the control arm (P5 0.018).
The control arm reported fewer days self-certified than the
intervention arm at a mean of 1.5 (SD 3.3) days compared with
3.9 (SD 15.0) days (P 5 0.001) (Table 3).
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3.5. Exploratory subgroup analyses
At 12 months, exploratory subgroup analyses showed that the
VA service was significantly more successful in those with
spinal pain compared with those with other musculoskeletal
pain (IRR 0.25, 95% confidence interval 0.10-0.62; Pinteraction 5
0.003). The intervention was also significantly more successful
in those who had work absence that exceeded 10 days at
baseline compared with those with absence periods of less
than 10 days (IRR 0.30, 95% confidence interval 0.11-0.83;
Pinteraction 5 0.020) (Table 3). Baseline level of self-efficacy to
return to work had little impact on the effect of the intervention
(Table 3).
3.6. Secondary outcomes
Self-reported time off work (binary yes/no) was examined as
a secondary outcome. Separate analysis compared the propor-
tions of participants in the 2 trial arms issuedwith a GP-certified fit
note, assessed through medical records (Table 3). Of the health-
related (secondary) outcome measures, there were few statisti-
cally significant differences between the intervention and control
Figure 2. CONSORT flow diagram. VA, vocational advice.
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arms for measures of pain, bothersomeness, pain self-efficacy,
Illness Perceptions Questionnaire (IPQ-R), Hospital Anxiety and
Depression Scale (HADS), and general health. Although estimated
differenceswere small, the health outcomeswere generally in favour
of the intervention arm (Table 4). Work-related measures demon-
strated statistically significant differences between arms, in favour of
the intervention arm, at both 4 and 12months in return-to-work self-
efficacy and performance at work, and a significant difference in
presenteeism at 4 months (Table 4).
3.7. Economic evaluation
The VA service resulted in greater mean benefits in terms of days
off work (6.7 fewer days off work; adjusted difference in time off
work over 12 months), at slightly higher NHS and health care
costs (cost difference of £48 and £15 for NHS and health care
perspectives, respectively) (Table 5). From an NHS perspective,
this resulted in an incremental cost-effectiveness ratio of £7.20
per day of absence avoided.
The net societal benefit of the addition of the VA service
compared with best current care alone was £733 (£748 gain
[work absenteeism] minus £15 loss [health care–related costs]),
demonstrating that the intervention represents more efficient use
of resources than the control (Table 5). The corresponding ROI
from a societal perspective was £49 (£733 divided by £15) that is,
every £1 invested in the VA service will return an estimated £49
($64USD). The inclusion of training costs and monthly mentoring
brings the ROI to £25 ($30USD).
The point estimate suggests that the intervention was more
effective (with fewer days off work) and associated with higher
costs than the control. eFigure 1 shows that for a willingness to
pay of £40 per sick day avoided, the probability that the
intervention is cost effective was slightly over 50% (available
online at http://links.lww.com/PAIN/A489).
Table 1
Baseline characteristics of trial participants by treatment
group.
Intervention
arm
Control
arm
n 5 158* n 5 180*
Age, mean (SD) 49.5 (9.6) 47.9 (10.7)
Sex, n (%)
Females 89 (56) 106 (59)
Males 69 (44) 74 (41)
Duration of symptoms, n (%)
,2 wk 19 (12) 28 (16)
2-6 wk 31 (20) 49 (28)
6-12 wk 28 (18) 29 (16)
3-6 mo 28 (18) 31 (18)
7-12 mo 16 (10) 15 (8)
.12 mo 35 (22) 25 (14)
Time since pain-free month, n (%)
,3 mo 53 (34) 58 (34)
4-6 mo 12 (8) 29 (17)
7-12 mo 24 (15) 22 (13)
1-3 yr 21 (13) 32 (18)
.3 yr 46 (30) 32 (18)
NRS-Pain average last 2 wk†, mean (SD) 6.9 (2.0) 7.0 (1.7)
NRS-Pain least pain last 2 wk†, mean (SD) 4.2 (2.4) 3.8 (2.5)
NRS-Pain intensity at present†, mean (SD) 5.6 (2.5) 5.4 (2.6)
NRS-Pain score summary†, mean (SD) 5.5 (1.9) 5.4 (1.8)
Bothersomeness, n (%)
Not at all 0 (0) 0 (0)
Slightly 3 (2) 3 (2)
Moderately 41 (26) 42 (23)
Very much 66 (42) 85 (47)
Extremely 48 (30) 50 (28)
General health, n (%)
Excellent 13 (8) 13 (7)
Very good 45 (28) 62 (34)
Good 61 (39) 66 (37)
Fair 31 (20) 29 (16)
Poor 8 (5) 10 (6)
HADS anxiety‡, mean (SD) 8.0 (4.4) 7.8 (4.1)
HADS depression§, mean (SD) 6.8 (4.3) 7.0 (4.2)
Working full time, n (%) 111 (71) 122 (68)
Time off work due to pain (past 12 mo), n (%) 87 (55) 113 (63)
Days off work (past 12 mo), mean (range) 15.0 (0-147) 17.8 (0-252)
Has self-certified, n (%) 43 (27) 57 (32)
Percent of days off through self-certification, 31 29
Has been issued a sick note/fit note, n (%) 60 (38) 82 (46)
Percent of days off through sick certification 69 71
Satisfaction with work║, mean (SD) 6.4 (2.5) 6.4 (2.4)
Performance at work{, mean (SD) 6.1 (2.6) 6.4 (2.9)
Stanford Presenteeism Scale#, mean (SD) 18.1 (5.4) 18.0 (5.4)
Self-efficacy—Return to Work**, mean (SD) 65.9 (27.6) 65.3 (28.8)
Current work situation, n (%)
Doing usual job 97 (61) 97 (55)
On paid annual leave/holiday 3 (2) 4 (2)
Working fewer hours 12 (8) 5 (3)
Doing lighter duties 7 (4) 9 (5)
On paid sick leave 35 (22) 51 (29)
Table 1 (continued)
Intervention
arm
Control
arm
n 5 158* n 5 180*
On unpaid leave 4 (3) 11 (6)
Difficulty managing at work, n (%)
Not at all 2 (1) 5 (3)
Slightly 23 (15) 34 (19)
Moderately 52 (34) 61 (34)
Very much 45 (29) 35 (20)
Extremely 32 (21) 44 (25)
NS-SEC, n (%)
1 16 (8.9) 2 (1.2)
2 35 (19.4) 40 (26.0)
3 36 (20.0) 28 (18.2)
4 4 (2.2) 13 (8.4)
5 9 (5.0) 12 (7.8)
6 41 (22.8) 32 (20.8)
7 39 (21.7) 27 (17.5)
Work is physically demanding, n (%) 110 (71) 119 (66)
Size of organisation .250 staff, n (%) 44 (29) 65 (37)
* Not all figures add to the corresponding group totals because of some missing baseline data.
† Numerical rating scale (NRS)-Pain scales are 0 to 10 where 0 5 no pain, 10 5 pain as bad as can be.
‡ Pain self-efficacy scale 0 to 60 where 0 5 no confidence, 60 5 highest confidence.
§ HADS anxiety/depression subscales 0 to 21 scales where 0 5 no anxiety/depression, 21 5 highest
anxiety/depression (clinical cutoffs are given as $8 “possible cases” and $11 “probable cases”).
║ Satisfaction with work 0 to 10 NRS scale where 0 5 not at all satisfied, 10 5 completely satisfied.
{ Performance at work 0 to 10 NRS scale where 05 not at all affected, 105 pain is so bad that unable to do job.
# Stanford Presenteeism (6-36 integer scale) where 6 5 lowest level of presenteeism, 36 highest level of
presenteeism.
** Self-efficacy Return to Work (0-114 scale) where 0 5 not at all confident, 114 5 totally confident.
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4. Discussion
The SWAP trial demonstrated that the addition of a low-intensity,
early access, VA service to best current primary care for adults
consulting with musculoskeletal pain led to fewer days off work
over 4 months, indicating some evidence for effect of the
intervention. The intervention improved measures of work
performance, presenteeism, and self-efficacy to return to work.
Use of the VA service for musculoskeletal pain was associated
with slightly higher costs, but the cost–benefit analysis demon-
strated the broader societal value of the VA service.
4.1. Implications
The VA service, also termed occupational advice and workplace
coaching, highlighted 2 key implications relating to the study
population and the intensity of intervention delivered.
4.1.1. Timing of the intervention
The sample included in the SWAP trial could be considered early in
their “work absence career”; patients were eligible if they were
struggling atwork aswell as those having a short period of absence
(less than 6 months). Although the addition of the VA service led to
significantly fewer days off work, exploratory subgroup analysis in
those participants with ,10 days absence vs $10 days but ,6
months absent at baseline found that the intervention was more
successful in those with the longer absence duration. Although
early intervention is advocated,4 these results suggest that a VA
intervention might be better targeted to those with more than 10
days (2 working weeks) of absence. van Duijn et al.9 reviewed the
literature around timing of interventions for individuals on sick leave
because of back pain, reporting the optimal window in which to
intervene as 8 to 12 weeks. These findings suggest the optimum
time to provide support in managing health and work is likely to be
after 10 days (approximately 2 working weeks) of absence, but this
needs testing in future studies.
4.1.2. Intensity of intervention delivered
The intervention provided in the SWAP trial was low intensity with
the majority of VA delivered by telephone. This is in keeping with
robust evidence that telephone-based VA can help a substantial
proportion of cases to self-manage their health problem and may
also facilitate return to work.6 There is evidence that simple, low-
intensity interventions provide similar benefits to complex,
multimodal interventions whilst avoiding unnecessary medical-
isation. This is particularly pertinent to the SWAP trial in which
participants had short term or no work absence and were in an
ideal position to manage their condition with appropriate advice
before their absence became long term. The model of stepped
care evaluated in the SWAP trial is similar to that proposed by
Burton et al.,6 requiring only those with more complex needs to
access costly face-to-face contact.
4.2. Strengths and limitations
The SWAP trial has a number of strengths. It is the first trial to
evaluate a VA service embedded in general practice offering
biopsychosocial advice to people with musculoskeletal pain,
a leading cause of work absence. The VA service was also
acceptable to patients with 75% (253 patients) of those offered
a referral accepting this offer. The SWAP trial is also the first to
intervene so early including those who were struggling at work,
with the aim of preventing future work absences. Although the
stepped care VA service was brief and mainly provided over the
telephone, thismethod is supported by the literature showing that
brief VA interventions are as effective as effort-intensive
interventions,25 and there are robust data to support telephone-
based interventions.6 The Department for Work and Pension’s
evaluation of the Fit For Work service pilots18 also found that low-
cost interventions (equating to low-intensity interventions) were
more likely to be the most cost effective, and many of these
interventions included populations with longer-term absence,
indicating that there would be utility in evaluating a similar VA
service in those with longer absence duration. A further strength
of this trial concerned activities to ensure continued engagement
with general practices. This included a range ofmeasures for both
the intervention and control practices comprising; provision of an
education session around managing health and work before the
trial commenced; regular contact with the trial team GP; a GP
“champion” in each practice who was the point of contact for the
trial. In intervention practices, VAs actively engaged in practice
life, joining breaks and staff meetings and providing both formal
and informal feedback about the service to GPs. This was
important, given the difficulty in engaging GPs in studies of VA
and has been reported by Rannard et al.26 and the Fit for Work
pilots.18 The finding that there was a difference in GP-certified
periods of absence could have been related to the visibility of the
VAs in the practice, suggesting that raising the profile of available
VA services providing VA may be of benefit. The qualitative
analyses conducted alongside this trial was unable to elucidate
the reasons for the decrease in the issue of fit notes,27 and further
work is needed to identify whether the availability of a VA service
does change GP behaviour reducing the issue of fit notes or
Table 2
Summary of VA service delivered.
Participants referred to VA service, n (% of
intervention group)
120 (76%)
At least 1 participant contact with the VA 97 (81%)
No. of contact attempts per participant, median
(IQR)
4 (2-5)
No. of actual contacts per participant, median
(IQR)
2 (1-3)
Contacts
Total number of participant contact attempts 489
Number of actual participant contacts 226 (37%)
Via telephone* 202 (89%)
Via face-to-face contact† 17 (8%)
Other (eg, letter) 7 (3%)
§ Duration of telephone call, median (IQR) 13.3 (10-20)
§ Duration of face-to-face visit, median (IQR) 60.0 (35-63.5)
Content of VA service
Exploration of health issues 197 (87%)
Exploration of work situation 176 (78%)
Oral information provided 138 (61%)
Assessment of obstacles/“flags”‡ 115 (51%)
Written information provided 20 (9%)
Explored work situation 11 (5%)
Developed Return-To-Work plan 7 (3%)
Number of stakeholder contacts 125
Figures are frequency count (percent) unless otherwise specified.
* All 17 face-to-face contacts were with 17 different participants (one of these face-to-face contacts was
carried out in the participant’s workplace).
† Stakeholder contacts were predominantly discharge letters to general practitioners.
‡ The flags framework is a system for identifying obstacles to working.
§ Time in minutes.
IQR, interquartile range; VA, vocational advice.
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whether accessing VA changes patients’ behaviour in asking for
certified absence.
There are several limitations. First, the association between the
intervention and the measures of work outcomes (return-to-work
self-efficacy, performance, and presenteeism) were influenced by
the adjustment of practice size because of the small number of
practices, 3 intervention and 3 control (practice size was adjusted
for as it was the only stratification variable used in randomisation).
Second, although 3 steps were available to the VAs in the delivery
of the VA service, only 1 workplace visit was undertaken (step 3),
the reasons for which need some consideration. The VAs within
the SWAP trial reported that participants were unwilling for them
to contact their employers. Many participants were very early in
their work absence and some were not currently absent, but
struggling at work; the lack of employer visits may reflect the trial
population and the primary care setting, where contact between
VAs and employers is uncommon, this is a finding in other similar
studies.8 A linked issue relates to the lack of recorded return-to-
work plans on the case report forms of patients accessing the VA
service in the intervention practices; this may be explained by the
early nature of the participants’ work absence. Although many
participants received at least 1 phone call from the VA, many had
already made their own plans to return to work and did not wish
for the VA to provide them with written documentation of this.
Third, there was the potential for recall bias to be introducedwhen
asking participants to recall their work absence over the past
months. To examine the potential for the introduction of recall
bias, a sensitivity analysis on the number of days off work was
performed using the medical record data, which should eliminate
recall bias. The findings of this sensitivity analysis again indicated
that the number of days off work was reduced in the intervention
arm. Last, the costs of presenteeism were not included in the
economic evaluation because the Stanford Presenteeism Scale
used could not be converted into a monetary value. Goetzel
et al.14 reported that presenteeism accounts for between 18%
and 60% of all costs of a range of health conditions. Given that
there were significant differences in measures of presenteeism in
favour of the intervention, it is likely that our health economic
analyses underestimated the cost effectiveness of the VA service.
In terms of the cost effectiveness of the intervention and the small
differences in costs and days off work, there remained some
uncertainty around estimates. A larger sample size would be able
to reduce this uncertainty and provide a better cost-effectiveness
interpretation. An appropriate threshold for this outcome needs to
be determined.
By way of a conservative estimate using data for back and neck
pain alone rather than all musculoskeletal pain conditions, 31 million
days are lost fromwork per year in the United Kingdom.24 If a similar
brief VA service was implemented widely, it could potentially reduce
this figure by 16%, equating to an overall societal cost saving of
approximately £500million (216milliondays lost per year, amounting
to an overall saving of $6 billion for the United States).
Table 3
Evaluation of the primary outcomemeasure (days off work) and key secondary outcomes relating to time off work over 4 and 12
months of follow-up.
4 months 12 months
Intervention arm Control arm IRR*/OR (95% CI) P Intervention arm Control arm IRR*/OR (95% CI) P
n 5 119 n 5 148 n 5 101 n 5 122
Days off work†, mean (SD) 9.29 (21.7) 14.4 (27.7) 0.51 (0.26-0.99) 0.048 20.3 (40.6) 24.3 (50.7) 0.65 (0.34-1.25) 0.198
Via self-certification 0.85 (4.11) 0.95 (3.81) 1.14 (0.50-2.56) 0.759 3.86 (15.0) 1.47 (3.27) 2.97 (1.60-5.52) 0.001
Via Fit note(s) 8.43 (21.0) 13.5 (27.5) 0.66 (0.46-0.94) 0.020 16.4 (34.2) 22.9 (50.5) 0.61 (0.41-0.92) 0.018
Subgroup analysis‡
Self-efficacy Return to Work§ 1.01 (0.87-1.17) 0.877 1.08 (0.93-1.26) 0.312
Spinal pain vs pain in other areas║ 0.69 (0.27-1.77) 0.440 0.25 (0.10-0.62) 0.003
Days-off (prior 12 mo){ 0.93 (0.78-1.11) 0.420 0.83 (0.67-1.03) 0.092
Exceeding 10 d# 0.42 (0.17-1.01) 0.053 0.30 (0.11-0.83) 0.020
Secondary outcomes
Any reported time off work**, n (%) 40 (33.6%) 56 (37.8%) 0.64 (0.33-1.23) 0.182 52 (50.5%) 64 (51.6%) 0.69 (0.34-1.38) 0.288
Medical record review
Fit note issued††, n (%) 51 (32.3%) 70 (38.9%) 0.53 (0.25-1.13) 0.103 52 (50.5%) 64 (51.6%) 0.55 (0.29-1.04) 0.065
Number of fit notes issued,
mean (SD)
0.68 (1.29) 0.94 (1.60) 0.60 (0.35-1.01) 0.053 1.11 (1.92) 1.51 (2.57) 0.63 (0.37-1.05) 0.073
Days off work, QL-QU (90th percentile; max) mean (range) intervention group 4 months: 0 to 5 (40; 84), via self-certification 0 to 0 (2; 40), via Fit note 0 to 0 (40; 84). Intervention group 12 months: 0 to 15 (80; 210), via self-
certification 0 to 0.3 (8; 126), via Fit note 0 to 10 (63; 188). Control group 4 months 0 to 10 (90; 84), via self-certification 0 to 0 (3; 42), via Fit note 0 to 10 (63; 188). Control group 12months 0 to 3 (75; 252), via self-certification
0 to 1 (5-19), via Fit note 0 to 25 (75; 252).
* Incidence rate ratio (IRR) was the effect of interest (except for self-report time off work [yes/no] and whether a fit note was issued to the participant [yes/no] where the effect of interest was odds ratio [OR]).
† Sensitivity analysis of primary outcome (days off work over 4 and 12 months of follow-up): (1i) zero-inflated negative binomial (ZINB) regression with robust variance estimator adjusted for age, sex, and practice size (IRR5
0.56 [P5 0.009] at 4 months and IRR5 0.65 [P5 0.107] at 12 months); (1ii) ZINB adjusted for age, sex, practice size plus baseline pain scores, and days off over the past 12 months (IRR5 0.57 [P5 0.004] at 4 months and
IRR5 0.79 [P5 0.391] at 12months); (2) nonparametric (Mann–Whitney U test) comparison of mean ranks (days off work aggregated at cluster [general practitioner level]) (P5 0.343 [4 months], P5 0.175 [12months]); (3i)
per protocol analysis (IRR5 0.52 [P5 0.005] at 4 months and IRR5 0.55 [P5 0.036] at 12 months); (3ii) complier average causal effect analysis based on 2-stage least squares instrumental variable with robust variance
(compliers defined as having at least 1 contact with the vocational advisor [n5 97]) (P5 0.051 [4 months], P5 0.147 [12months]). (4) General practitioner practice as a random factor (cluster variable) (P5 0.019 [4 months],
P 5 0.198 [12 months]).
‡ Subgroup analyses as prespecified in the published study protocol.
§ Units denote 10-point increments on the self-efficacy scale.
║ Days off over 4 months of follow-up: (1) control group, no spine pain (n5 55, mean5 10.4, SD 24.7); (2) control group, spine pain (n5 93, mean5 16.8, SD 29.2); (3) intervention group, no spine pain (n5 42, mean5
15.1, SD 26.0); (4) intervention group, spine pain (n5 77, mean5 6.1, SD 18.3); days off over 12 months of follow-up: (1) control group, no spine pain (n5 46, mean5 11.8, SD 22.1); (2) control group, spine pain (n5 76,
mean 5 32.0, SD 60.8); (3) intervention group, no spine pain (n 5 34, mean 5 32.0, SD 54.0); (4) intervention group, spine pain (n 5 67, mean 5 14.3, SD 30.6).
{ Units denote 20-day increments (ie, approximately 1 month) on the scale of days off work.
# Additional subgroup analysis requested by TSC.
** Time off work (yes/no)—frequency counts (percent) are for participants who reported having had time off work.
†† Agreement between self-reported time off work (yes/no) and medical record review of issuing of fit note(s) (yes/no) was 70% (187/267) over 4 months and 62% (146/234) over 12 months.
CI, confidence interval.
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Table 4
Evaluation of secondary outcome measures over 4 and 12 months of follow-up.
4 months 12 months
Intervention
arm
Control
arm
MD*/OR† (95% CI) P Intervention
arm
Control
arm
MD*/OR† (95% CI) P
Pain related
NRS-Pain average last 2 weeks,
mean (SD)
4.3 (2.8) 5.1 (2.8) 20.78 (21.61 to 0.04)* 0.063 3.6 (3.0) 4.4 (2.4) 20.76 (21.82 to 0.30)* 0.159
NRS-Pain least pain last 2
weeks, mean (SD)
2.9 (2.5) 3.1 (2.5) 20.20 (21.05 to 0.64)* 0.636 2.3 (2.6) 2.4 (2.3) 20.09 (21.03 to 0.85)* 0.854
NRS-Pain intensity at present,
mean (SD)
3.3 (2.7) 4.0 (2.9) 20.63 (21.58 to 0.32)* 0.191 2.8 (3.0) 3.6 (2.6) 20.86 (21.96 to 0.23)* 0.122
NRS-Pain score summary, mean
(SD)
3.5 (2.5) 4.1 (2.5) 20.56 (21.37 to 0.24)* 0.172 2.9 (2.7) 3.5 (2.3) 20.59 (21.56 to 0.38)* 0.231
Global change, n (%)
Completely recovered 6 (6) 5 (4) 0.87 (0.35 to 2.13)† 0.753 11 (13) 8 (7) 0.96 (0.32 to 2.85)† 0.939
Much improved 18 (18) 33 (27) 25 (30) 38 (35)
Somewhat improved 27 (27) 31 (26) 12 (15) 25 (23)
Same 28 (28) 29 (24) 16 (20) 26 (24)
Somewhat worse 15 (15) 18 (15) 10 (12) 10 (9)
Much worse 5 (5) 5 (4) 8 (10) 2 (2)
Bothersomeness, n (%) 0.82 (0.36 to 1.87)† 0.635 0.44 (0.20 to 1.01)† 0.052
Not at all 2 (2) 3 (2) 7 (7) 4 (3)
Slightly 22 (19) 35 (25) 24 (23) 26 (21)
Moderately 44 (38) 47 (33) 34 (32) 51 (41)
Very much 30 (26) 39 (27) 27 (26) 38 (30)
Extremely 17 (15) 18 (13) 13 (12) 6 (5)
Psychological variables and general
health
Pain self-efficacy scale, mean
(SD)
41.0 (15.1) 38.0 (14.6) 3.00 (21.52 to 7.53)* 0.193 44.7 (14.8) 42.9 (12.2) 1.84 (23.14 to 6.82)* 0.470
Illness Perceptions (IPQ-R Short
Form), n (%)
— — — —
Identity, median (IQR) 5 (3-5) 5 (4 to 5) 20.24 (20.62 to 0.14)* 0.213 5 (3 to 5) 4 (3 to 5) 20.10 (20.57 to 0.38)* 0.681
Timeline, n (%) 71 (68.9) 77 (61.1) 0.79 (0.21 to 2.97)† 0.732 44 (53.0) 66 (60.0) 0.19 (0.04 to 0.91)† 0.037
Consequences, n (%) 58 (56.3) 64 (50.8) 0.40 (0.09 to 1.83)† 0.239 34 (40.5) 44 (40.0) 0.36 (0.05 to 2.52)† 0.304
Personal control, n (%) 49 (48.5) 56 (45.9) 3.41 (1.08 to 10.7)† 0.036 40 (48.8) 55 (50.5) 1.65 (0.43 to 6.32)† 0.464
Treatment control, n (%) 70 (69.3) 76 (62.3) 1.27 (0.46 to 3.49)† 0.639 45 (54.2) 63 (57.3) 0.97 (0.32 to 2.90)† 0.952
Illness coherence, n (%) 23 (22.8) 29 (23.8) 0.72 (0.20 to 2.57)† 0.618 12 (14.5) 24 (21.8) 0.11 (0.01 to 0.81)† 0.031
Timeline cyclical, n (%) 50 (49.5) 60 (49.2) 1.77 (0.58 to 5.39)† 0.315 30 (36.1) 67 (60.9) 0.17 (0.04 to 0.75)† 0.019
Emotional representation, n
(%)
65 (64.4) 86 (70.5) 0.30 (0.07 to 1.22)† 0.093 47 (56.6) 59 (54.1) 0.54 (0.11 to 2.64)† 0.445
HADS anxiety, mean (SD) 6.6 (4.7) 7.9 (4.3) 21.31 (22.63 to 0.00)* 0.050 6.6 (4.1) 7.1 (4.0) 20.52 (21.92 to 0.87)* 0.461
HADS depression, mean (SD) 5.7 (4.2) 6.1 (3.9) 20.37 (21.64 to 0.91)* 0.572 4.7 (3.9) 5.2 (3.8) 20.47 (21.81 to 0.87)* 0.489
General health, n (%) 1.01 (0.33 to 3.07)† 0.985 0.39 (0.12 to 1.26)† 0.116
Excellent 8 (8) 8 (6) 4 (5) 4 (4)
Very good 29 (29) 30 (24) 27 (34) 36 (33)
Good 32 (32) 54 (43) 29 (36) 46 (42)
Fair 26 (26) 30 (24) 17 (21) 21 (19)
Poor 6 (6) 4 (3) 3 (4) 3 (3)
Work related
Stanford Presenteeism Scale,
mean (SD)
21.3 (5.4) 19.1 (5.9) 2.23 (0.35 to 4.10)* 0.020 22.0 (5.6) 20.1 (5.7) 1.89 (20.24 to 4.03)* 0.082
Self-efficacy—Return to Work,
mean (SD)
81.5 (26.8) 70.1 (27.2) 11.4 (2.97 to 19.8)* 0.008 82.6 (27.1) 73.7 (24.1) 8.91 (0.04 to 17.8)* 0.049
Satisfaction with work, mean
(SD)
6.4 (2.8) 6.0 (2.3) 0.38 (20.45 to 1.20)* 0.369 6.2 (2.6) 6.1 (2.3) 0.06 (20.83 to 0.95)* 0.894
Performance at work, mean (SD) 4.1 (2.8) 5.1 (3.0) 21.05 (21.96 to 20.14)* 0.023 3.4 (3.1) 4.6 (2.9) 21.11 (22.12 to 20.09)* 0.032
Descriptive summaries are marginal mean (SD) or frequency count (percent) as appropriate to the type of data being summarised (numerical or categorical, respectively).
* MD 5 mean difference (by linear mixed model).
† OR5 odds ratio (by binary/ordinal logit mixed model) adjusted for age, sex, and practice size. Attitudes and beliefs (patients) re: work and health will be reported elsewhere to allow the measure to be developed. The content
of the general practitioner/nurse practitioner consultation and questions regarding treatment satisfaction will also be reported separately.
CI, confidence interval; IQR, interquartile range; NRS, numerical rating scale.
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4.3. Future research
Future research should build upon the intervention provided in the
SWAP trial, refining the timing of the intervention to those who
have at least 10 days work absence. Given that the results
demonstrate benefits in patients with musculoskeletal pain,
developing and testing VA services with broader patient groups
in primary care such as those with mental health conditions and
cardiovascular disease would also be helpful.
5. Conclusions
Study of Work and Pain is the first trial to evaluate an intervention
embedded in primary care providing early VA, based on biopsy-
chosocial principles, for patients with musculoskeletal pain. The
trial demonstrated a reduction in days off work in favour of the VA
intervention, an increase in self-efficacy to return to work,
reduced presenteeism, and improved performance at work.
Greater economic benefits were seen from the addition of the VA
intervention compared with best current primary care alone.
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